Socrus Bio Sciences Ltd. - Research Center
524719 SOCRUSBIO Group (Z) BSE data
Results
Statement
More
| Mar ' 13 |
Mar ' 12 |
Mar ' 11 |
Mar ' 10 |
Mar ' 09 |
Equity share capital
| 32.00 |
32.00 |
32.00 |
14.65 |
14.65 |
Share application money
Preference share capital
Reserves & surplus
| -30.73 |
8.63 |
3.51 |
-2.63 |
-2.78 |
Secured loans
Unsecured loans
Total
| 1.27 |
40.64 |
35.52 |
12.02 |
11.88 |
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
| 2.24 |
18.02 |
12.83 |
11.40 |
11.20 |
Less : current liabilities & provisions
Total net current assets
| 1.27 |
17.96 |
12.79 |
11.38 |
11.16 |
Miscellaneous expenses not written
Total
| 1.27 |
40.64 |
35.52 |
12.02 |
11.88 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
| 320.03 |
320.03 |
320.03 |
146.53 |
146.53 |